Why the study?
Cardiovascular diseases are a major source of global morbidity, and early detection of individuals at risk would allow medical professionals more time to intervene. This review summarizes popular machine learning algorithms and related challenges for predicting heart disease risk.
Do machine learning algorithms improve the early detection and risk stratification of heart disease in patients?
Do machine learning algorithms improve the early detection and risk stratification of heart disease in patients?
Answers are grounded in this paper and cite their sources.
While machine learning models can stratify patients by heart disease risk, results from small benchmark datasets are often overly optimistic and require rigorous preparation, interpretation, and external hospital validation to achieve clinical relevance.
Cardiovascular diseases have become one of the major sources of morbidity in the world, therefore early detection of the people at risk would allow medical professionals more time to act. One of the approaches to the problem through ML is the use of the information that includes such variables as age, blood pressure, total cholesterol, blood glucose, heart rate, symptoms of the patient, and test results. In this paper, we give a brief description of the most popular algorithms for predicting the risk of heart diseases using ML: Logistic Regression, Support Vector Machine, Decision Tree, Random Forest, Naïve Bayes, K-Nearest Neighbors, and Neural Networks. Deep learning, Explainable AI (XAI), small data, class imbalance, bad data quality, privacy, and hospital validation will also be discussed. This narrative literature review is based on the synopsis of the project, some pieces of literature, and dataset documentation. There was no training of any ML model nor conducting of any experiments. As it follows from the papers under study, ML allows to separate patients into risky and non-risky categories; however, the results strongly depend on the selected dataset, goal of prediction, validation method, and patients themselves. Results from small benchmark datasets tend to be highly optimistic and cannot be used to predict clinical relevance of the models. We also present a process flow of how the data should be prepared, modeled, evaluated, interpreted and externally validated and hope that such models will help physicians more than replace them.
No takes yet. Share an insight, caveat, or question.
Gaikwad et al. (2026) conducted a review in Cardiovascular disease / Heart disease. Machine learning algorithms for heart disease risk prediction was evaluated on Early detection and risk stratification of heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: